Home Clinical Topics FDA approves new MRI agent

FDA approves new MRI agent

Author(s):

The U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here